Authors: SONNEVELD P SUCIU S WEIJERMANS P BEKSAC M NEUWIRTOVA R SOLBU G LOKHORST H VANDERLELIE J DOHNER H GERHARTZ H SEGEREN CM WILLEMZE R LOWENBERG B

Citation: P. Sonneveld et al., CYCLOSPORINE-A COMBINED WITH VAD VS VAD IN PATIENTS WITH REFRACTORY MULTIPLE-MYELOMA - AN EORTC HOVON RANDOMIZED PHASE-II STUDY/, Blood, 90(10), 1997, pp. 1590-1590

Authors: DEWITTE T SUCIU S BOOGAERTS M LABAR B ARCHIMBAUD E AUL C SELLESLAG D FERRANT A WEIJERMANS P MANDELLI F AMADORI S MUUS P DEMUYNCK H DARDENNE M WILLEMZE R GRATWOHL A APPERLEY J

Citation: T. Dewitte et al., INTENSIVE ANTILEUKEMIC THERAPY INCLUDING STEM-CELL TRANSPLANTATION (SCT) FOR HIGH-RISK MDS AND AML FOLLOWING MDS (SAML) IN PATIENTS LESS-THAN-60 YEARS - A JOINT STUDY OF THE EORTC AND THE EBMT LEUKEMIA GROUPS, Experimental hematology, 24(9), 1996, pp. 678-678

Authors: DEWITTE,"SUCIU S BOOGAERTS M LABAR B ARCHIMBAUD E AUL C SELLESLAG D FERRANT A WEIJERMANS P MANDELLI F AMADORI S JEHN U MUUS P DEMUYNCK H DARDENNE M WILLEMZE R GRATWOHL A APPERLEY J

Citation: S. Dewitte,"suciu et al., THE INFLUENCE OF CYTOGENETIC ABNORMALITIES ON TREATMENT OUTCOME AFTERINTENSIVE ANTILEUKEMIC THERAPY FOR PATIENTS WITH HIGH-RISK MDS AND AML FOLLOWING MDS, Blood, 88(10), 1996, pp. 1806-1806

Authors: MATTIJSSEN V",DEWITTE,"SUCIU S BOOGAERTS M LABAR B ARCHIMBAUD E AUL C SELLESLAG D FERRANT A WEIJERMANS P MANDELLI F AMADORI S JEHN U MUUS P DEMUYNCK H DARDENNE M WILLEMZE R GRATWOHL A APPERLEY J

Citation: S. Mattijssen V",dewitte,"suciu et al., THE PROGNOSTIC IMPACT OF THE PRESENCE OF AN HLA-IDENTICAL DONOR ON PATIENTS WITH HIGH-RISK MDS AND AML FOLLOWING MDS TREATED WITH AN INTENSIVE ANTILEUKEMIC REGIMEN, Blood, 88(10), 1996, pp. 1908-1908